{
  "name" : "twin.sci-hub.se_6398_c8d4cd9614e5412cf900dae5f159f653_kubasiewicz-ross2017.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : null,
    "authors" : [ "Paweł Kubasiewicz-Ross", "Jakub Hadzik", "Julia Seeliger", "Karol Kozak", "Kamil Jurczyszyn", "Hanna Gerber", "Marzena Dominiak", "Christiane Kunert-Keil" ],
    "emails" : [ "christiane.kunert-keil@uniklinikum-dresden.de" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Accepted Manuscript\nTitle: New nano-hydroxyapatite in bone defect regeneration: a histological study in rats\nAuthors: Paweł Kubasiewicz-Ross, Jakub Hadzik, Julia Seeliger, Karol Kozak, Kamil Jurczyszyn, Hanna Gerber, Marzena Dominiak, Christiane Kunert-Keil\nPII: S0940-9602(17)30085-7 DOI: http://dx.doi.org/doi:10.1016/j.aanat.2017.05.010 Reference: AANAT 51168\nTo appear in:\nReceived date: 23-3-2017 Revised date: 9-5-2017 Accepted date: 30-5-2017\nPlease cite this article as: Kubasiewicz-Ross, Paweł, Hadzik, Jakub, Seeliger, Julia, Kozak, Karol, Jurczyszyn, Kamil, Gerber, Hanna, Dominiak, Marzena, Kunert-Keil, Christiane, New nano-hydroxyapatite in bone defect regeneration: a histological study in rats.Annals of Anatomy http://dx.doi.org/10.1016/j.aanat.2017.05.010\nThis is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.\nNew nano-hydroxyapatite in bone defect regeneration: a histological study in rats\nRunning title: Nano-hydroxyapatite in the bone regeneration\nPaweł Kubasiewicz-Rossa1, Jakub Hadzika1, Julia Seeligerb, Karol Kozakb, Kamil Jurczyszyna, Hanna Gerberc, Marzena Dominiaka, Christiane Kunert-Keilb*\naDepartment of Oral Surgery, Wroclaw Medical University, ul. Krakowska 26, 50-425 Wrocław, Poland bDepartment of Orthodontics, Carl Gustav Carus Campus, Technische Universität Dresden, Fetscherstr. 74, D-01307 Dresden, Germany cDepartment of Maxillo-Facial Surgery Wroclaw Medical University, 50-556 Wrocław, ul.Borowska 213, Wrocław, Poland\n*corresponding author: PD Dr. Christiane Kunert-Keil Department of Orthodontics, Carl Gustav Carus Campus, Technische Universität Dresden Fetscherstr. 74 D-01307 Dresden, Germany Tel. 0049-351-4582718 Fax: 0049-351-4585318 Mail: christiane.kunert-keil@uniklinikum-dresden.de\n1Authors contributed equally"
    }, {
      "heading" : "Abstract",
      "text" : "Many types of bone substitute materials are available on the market. Researchers are refining new bone substitutes to make them comparable to autologous grafting materials in treatment of bone defects. The purpose of the study was to evaluate the osseoconductive potential and bone defect regeneration in rat calvaria bone defects treated with new synthetic nanohydroxyapatite. The study was performed on 30 rats divided into 5 equal groups. New preproduction of experimental nano-hydroxyapatite material by NanoSynHap (Poznań, Poland) was tested and compared with commercially available materials. Five mm critical size defects were created and filled with the following bone grafting materials: 1) Geistlich Bio-Oss®; 2) nano-hydroxyapatite + β-TCP; 3) nano-hydroxyapatite; 4) nano-hydroxyapatite + collagen membrane. The last group served as controls without any augmentation. Bone samples from calvaria were harvested for histological and micro-ct evaluation after 8 weeks. New bone formation was observed in all groups. Histomorphometric analysis revealed an amount of regenerated bone between 34.2 and 44.4% in treated bone defects, whereas only 13.0% regenerated bone was found in controls. Interestingly, in group 3, no significant particles of the nano-HA material were found. In contrast, residual bone substitute material could be detected in all other test groups. Micro-CT study confirmed the results of the histological examinations. The new nano-hydroxyapatite provides comparable results to other grafts in the field of bone regeneration.\nKeywords: bone defect, guided bone regeneration, nano-hydroxyapatite"
    }, {
      "heading" : "Introduction",
      "text" : "Bone defects caused by tumor resection, trauma, infection and congenital anomalies\nremain an important challenge in the field of oral and maxilla-facial surgery. Clinical treatment of such defects involves the use of natural grafting materials, like autologous grafts, allogenic grafts, or synthetic grafting materials (Takahashi et al., 2005; Kunert-Keil et al., 2011). The term “bone graft” was defined by Bauer and Muschler as: “any implanted material that alone or in combination with other materials promotes a bone healing response by providing osteogenic, osteoinductive or osteoconductive properties” (Bauer and Muschler, 2000). Materials for bone grafting can be harvested and implanted in the same individual (autologous, autografts), obtained from a different individual of the same species (allogenic, allografts), from a different species (xenogenic, xenografts). Furthermore synthetic\nbiomaterials materials (alloplastic, alloplasts) are widely used. Autologous bone graft alone or with the combination of a particulate bone graft and bone substitute materials are still considered a golden standard of bone augmentation due to the fact that only the autogenous bone has the osteogenic, osteoinductive and osteoconductive properties (Bauer and Muschler, 2000; Takahashi et al., 2005; Kunert-Keil et al., 2011). The main disadvantage in the use of autologous bone is the necessity of an additional procedure to harvest the graft from the donor site which can result in possible complications, such as limited graft quantity and risk of disease transmission. Artificial biomaterials, such as hydroxyapatite, are useful alternatives to autologous materials. Since no bone substitution material has shown similar osteogenic properties to autologous bone up-to-date, new materials are being sought (Takahashi et al., 2005; Kunert-Keil et al., 2011). Calcium phosphates such as hydroxyapatite (HA), Ca10(PO4)6(OH)2, and beta-tricalcium phosphate (β-TCP), Ca3(PO4)2, composed of the same ions as the main mineral constituent of bone, are attractive implant materials for bone regeneration because they are biocompatible, osteoconductive, and produce no systemic toxicity or immunological reactions (LeGeros, 2002; Giannoudis et al., 2005). Until now, HA-based biomaterials are the most abundant materials used in modern bone substitution (Noetzel and Kielbassa, 2005; Gotz et al., 2008; Hamerschmidt et al., 2011; Canullo et al., 2013; Kunert-Keil et al., 2015). At the moment calcium phosphate cements play a secondary role in dentistry, although they often have an excellent biocompatibility (Noetzel and Kielbassa, 2005). HA can be obtained from natural materials e.g. coral or animal bone or by synthetic methods. There are numerous methods of obtaining HA, including: wet, dry, flux and sol-gel reactions, however, the most popular method is the wet method (Bucholz, 2002; LeGeros, 2002; Giannoudis et al., 2005). Particular methods facilitate acquisition of an appropriate material morphometry, crystal structure and proper molar ratio Ca/P as well as insertion of foreign ions into a crystalline structure. Unfortunately, there is no method able to recreate the ideal microstructure of HA for bone grafting. HA, in opposition to β-TCP, slowly resorbs material. In vivo degradation of HA occurs by aqueous dissolution in body fluids, resorption by osteoclasts and multinuclear cells, and phagocytosis of particles by macrophages. The process is slow, which is why HA is currently used for bone tissue repair in non-load-bearing applications. For load-bearing applications, HA is usually combined with β-TCP. During degradation and the resorption of β-TCP space for new bone formation is provided (Garagiola et al., 2016). For the same purpose (faster resorption), the nano-hydroxyapatite (nano-HA) was used in bone defect regeneration. Bone tissue is a biocomposite of collagen as the organic part and nano-HA as\nthe inorganic part. Using nano-HA in synthetic grafts with crystals resembling natural bone, the bioactivity is enhanced compared to use of larger size HAP particles. Additionally, use of nano-HA has a positive effect on protein adhesion, cell adhesion and proliferation (Garagiola et al., 2016; Teotia et al., 2017).\nOf the most essential aspects in the characterization of HA-ceramics are the size of the\ngranules and porosity. It has been shown that both pore size and porosity have effects on mineralization and bone formation (Harris and Cooper, 2004; Kruyt et al., 2004). The nanometer grain sizes and high porosity of surface increase osteoblast function and allows for faster proliferation, adhesion and differentiation (Karageorgiou and Kaplan, 2005). Nonetheless, it was has been reported that high porosity and small sizes of the granules influence the graft resorption and bone ingrowth (van Eeden and Ripamonti, 1994). Another option is to combine the HA with calcium sulfate (CS). When HA remains intact, the CS rapidly resorbs providing porous scaffold for cells and vessel ingrowth. Additional application of the bisphosphonates to such composed material can rule the time of CS resorption in order to achieve better properties (Puljula et al., 2015). Recently, studies have shown that the HA in combination with CS can locally deliver drugs and growth factors (e.g. bone morphogenic proteins (BMP) (Teotia et al., 2016). Many efforts have recently been directed at evaluating the role of vascularization of the graft. Du and coworkers demonstrated that incorporation of the vascular endothelial growth factor (rh-VEGF) in the material enhances the angiogenesis of the graft material (Du et al., 2015). Nonetheless, much effort is being conducted in this field to find the best combination of chemical composition, surface properties and granules dimensions of the HA-ceramics. Therefore, the aim of our study was to evaluate the characteristics of the nano-hydroxyapatite manufactured in a new unique method that provides a high porosity and small granulation of pure hydroxyapatite in histological and micro-CT investigation in rat calvaria model."
    }, {
      "heading" : "Materials and methods",
      "text" : ""
    }, {
      "heading" : "Preparation and characterization of the ceramics",
      "text" : "The ceramics were prepared as experimental material in by our group in cooperation with the NanoSynHap company (NanoSynHap, Poznań, Poland) using a unique method of wet precipitation combined with the sol/gel reaction at a relatively low temperature 500-800 ºC enabling to achieve pure nano-Hydroxyapatite (nano-HA) of chemical formula: Ca10(PO4)6 (OH)2 in granules with diameters less than 100 nm and porosity up to 70% as well as porous\ndiameter of approximately 50 µm, respectively. Hydroxyapatite is a slightly soluble compound crystallizing in hexagonal structure of the density near the 3.16 g/cm3. The nanoHA was provided in the form of dense paste that can be easily inserted in bone defect. The detailed description of the synthesis method of the new nano-HA is not provided due to patent application."
    }, {
      "heading" : "Animal experiment",
      "text" : "The experimental protocol was approved by the Local Animal Welfare Committee (9/2014). To determine the minimum sample size needed to obtain statistical differences between animal species and three types of materials, the sample sizes were estimated by applying the equation for comparative studies. The study protocol was analogous to our previously studies [7,8]. Surgery was performed on Wistar rats (200–250 g, male) at the Experimental Animal Centre of the Wrocław Medical University.\nThe 30 animals were randomly divided into 5 equal groups depending on the type of biomaterial used: Group 1: Geistlich Bio-Oss® granules size 0.25 mm (Geistich AG, Wolhusen, Switzerland) Group 2: nano-hydroxyapatite (nano-HA) in combination with β-TCP Group 3: nano-HA Group 4: nano-HA covered by the Jason® collagen membrane (Botiss biomaterials GmbH, Germany) Group 5: Control group, defects without augmentation. Every animal was treated in the same way. After anesthesia of the animals with 3% sodium pentobarbital with Ketamine (60 mg/kg body weight; CEVA Tiergesundheit, Düsseldorf, Germany) the operation sites were shaved and the skin was sterilized with iodine. Then local anesthesia of 2% lignocaine (Polfa Warszawa, Poland) was provided. A longitudinal incision of about 3 cm was created and calvaria bone was exposed [Fig.1]. Bone defects of 5 mm diameter were created with a low speed drill under permanent saline cooling. The defects were situated in the middle of the sagittal plane of the calvaria [Fig. 2] and completely filled with the different materials except for the control group [Fig. 3, 4]. The wound was closed with a cutaneous single interrupted suture 5/0 (Safil 5/0 USP, Braun). After surgery, penicillin was administered intramuscularly for 3 consecutive days to prevent infection. Animals were sacrificed by an overdose of sodium pentobarbital 8 weeks post insertion of the materials in a randomized manner. Calvaria of each animal were once again exposed and bone\ntissue was taken for further investigation. The samples were first commissioned to micro-ct evaluation. For the analysis, a CBCT scanner was used (3D Accuitomo-XYZ Slice View Tomograph; J. Morita Mfg Corp., Kyoto, Japan) with exposure parameters of 90 kV, 3.0 mA, a 17.5 s scan, 0.16 slice intervals and 0.16 mm slice thickness data. Moreover, the study protocol included the histological examination. For that, the specimens taken from the test sites were immersed in 4 % buffered formalin for one week at room temperature and then embedded in paraffin. Serial longitudinal sections of about 5 µm were stained with hematoxylin/eosin (H.E.) for recognizing various tissue types and Masson Goldner trichrome for differentiation between collagen, muscle and bone tissue. Histological preparations were subjected to microscopic evaluation consisting of assessment of the type and quality of tissue filling the defect as well as the nature of cells covering the surface of the bone defect. Histomorphometric analyses were evaluated by 2 independent observers and performed on composed pictures showing the complete cavity at a magnification of x100 as described previously (Gredes et al., 2015; Kunert-Keil et al., 2015). The new bone formation and the line between old and new bone was marked. Bone regeneration was measured and averaged at a plurality of places. Bone regeneration was expressed as a percentage of bone height of the main bone in the periphery of the lesions."
    }, {
      "heading" : "Statistics",
      "text" : "All statistical analyses were performed using the Statistica 10 software (StatSoft Polska Sp., Kraków, Poland). Statistical analyses were made using Tukey’s post hoc test. All data are given as means ± standard deviation (SD). P < 0.05 was considered statistically significant."
    }, {
      "heading" : "Results",
      "text" : "Postoperatively, the rats recover quickly, returning to routine activities such as grooming, eating and drinking in less than 48 hrs. Regardless of the used material there were no macroscopic or microscopic signs of cellular inflammation or bone graft material rejection in any of the testes groups. Histological analysis showed new bone formation in all groups after 8 weeks. Furthermore, well-vascularized connective tissue filled the spaces between the grafted material residues or the bone defect. Additionally, the newly formed bone and blood vessels had grown toward the centers between macropores through the interconnecting paths. Occasional osteoblast like cells were found at the surface of granules (Figure 5-8). No microscopic signs of inflammation or foreign body reaction were found. In the control group (Group 5; no biomaterial), bone formation was limited to the defect margins and the defect regeneration\nwas 13 ± 6.28 % (Fig. 5 and table 1). In group 1, 2, 3 and 4, new bone apposition was observed around the defect and the bone graft particles (Fig. 6-9). Interestingly, in group 3, only residues of the bone substitute material (nano-HA) could be detected, while, in group 4, particles were still present (Fig. 7+8). Histomorphometric analysis revealed an amount of regenerated bone between 34.2 and 44.4% in treated bone defects, respectively (table 1). The best results of bone regeneration were achieved for xenogenic Bio-Oss (44.4 ±8.8%) and for the group of new nano-HA with additional application of the Jason® collagen membrane (39.1 ±8.2%). Statistically important differences were found between bone formations in all treated groups (group 1-4) in comparison with the untreated control group. However, between the different bone substitution materials as well as combinations no statistically important differences in defect healing were found (table 2). Although we did not perform immunostaining for Micro-CT, this study confirmed the results of the histological examinations After 8 weeks, the qualitative differences in the amount of mineralized volume between the groups were observed in radiological images of the defect site. Based on quantitative micro-CT analysis, the mineralized volume was highest in group 1 followed by the group 4 (Fig. 10)."
    }, {
      "heading" : "Discussion",
      "text" : "To examine new bone substituting material, suitable bone defects must be established in vivo through the use of appropriate animal models. Animal models allow for standardization or elimination of variables which contribute to the success or failure of tissue engineered materials (Khan and Lane, 2004; Horner et al., 2010). Thus it is very important to choose the appropriate model and research protocol to effectively analyze the results of a specific study. When choosing a species of animal for a particular study model or specific research method several factors should be considered, including costs, ease of housing, availability, acceptability of society, biologic characteristics analogous to human. In the present study, the rat calvaria model was established. Rodent and canine models are very often used for evaluation of horizontal ridge augmentation (Pellegrini et al., 2009; Seol et al., 2010). The areas of the rodent skeleton that can used in that purpose are: the femora, spine, mandible and calvarium (Wang et al., 2003; Kempen et al., 2008; Kempen et al., 2009a; Kempen et al., 2009b; Henslee et al., 2011). First described in 1973 and confirmed 10 years later the rat calvarium allows for a reproducible defect that can be generated quickly and does not require fixation for stabilization of the skeleton (Freeman and Turnbull, 1973; Takagi and Urist,\n1982), as is generally required with femoral defects. The reasons why calvaria gained popularity for use in the discussed purposes are mostly due to the following: the calvaria bone structure allows for reproducibility of the defects that are easily evaluated by radiographic and histological analysis; the anatomic location allows for surgical approach and facilitates surgical protocol; and the model has been widely used and studied, allowing a precise comparison of grafted substances (Schmitz and Hollinger, 1986; An and Friedman, 1999; Gredes et al., 2012c; Kunert-Keil et al., 2015). Nonetheless, it does not allow the assessment of the biological response of the implanted material to a physiological biomechanical loading which may be a limitation in some applications. In order to stress the bone healing ability of an organism to nonunion, the critical-size defect must be large enough to create a non-viable space that inhibits indirect bone healing to bridge the defect (Schmitz and Hollinger, 1986). In the present study, a bone defect of 5 mm was created. Honma et al. evaluated the originality of bone tissue healing in rat model and defined the critical-size defect of the rat calvarium. According to research reports, the size of bone defect than can be healed by the restitutio ad integrum should not be larger than 8.8 mm in diameter. They also established the definition of subcritical defects with a diameter of 3.8 mm. New bone formation was observed in both defect sizes, with small defects being almost completely filled by 24 weeks, while large defects remained unrepaired, becoming non-union with fibrous connective tissue in the areas in which bone formation was absent (Honma et al., 2008). Based on this work, our defect size is included in the so-called non-critical bone defects with the ability to heal without any treatment. Early works, in the 1970s, by Najjar and Kahn showed that bone wounds will be filled at first with well vascularized connective tissue, followed by immature bone replacement, which was, in turn, remodeled into mature bone (Najjar and Kahn, 1977). Our study has shown new bone apposition in the defect filled with xenogenic bovine derived bone substitute as well as nano-hydroxyapatite (nano-HA) in combination with β-TCP alone or with additional application of the membrane. Bone defects and the spaces between the grafted material residues were filled with well-vascularized connective tissue. This is in accordance with earlier published results when using calcium phosphate ceramics in both rat and humans (Gotz et al., 2008; Canullo et al., 2013; KunertKeil et al., 2015). Investigation of the healing of a nano-crystalline synthetic HA demonstrated sprouting vessels from pre-existent host vessels entering the un-degraded granules. Later, these vessels form an intergranular network which probably transports osteoblastic precursor cells into the granules (Gotz et al., 2008). This is maybe relevant for\nosteoconductive and probably also osteoinductive features of HA leading to early osteogenesis, and subsequent remodeling of the newly formed bone (Gotz et al., 2010).\nFurthermore, it was found that the bone formation was significantly increased in\ntreated bone lesions compared to untreated bone tissue. However, no statistically significant differences were found between bone regeneration with the new nano-HA alloplastic material and a commercially available xenograft with highly proved osteoconductive potential. In our study, the bone defect regeneration with nano-HA in combination with the membrane reached 39.1%, whereas Bio-Oss® granules create an amount of 44.4%. However, it must also be pointed out that the bone regeneration in this study was much lower than previously described. The literature shows various results of bone defect regeneration caused by HAceramics reaching even up to 68.53% (Hamerschmidt et al., 2011). Thus, the new material is comparable to the conventional, well-studied material and can be used in its place. It might even be more useful because, as in group 3, only residues of the bone substitute material (nano-HA) could be detected, while in group 4 particles were still present. This phenomenon may be caused by the collagen membrane that might slow the HA particles resorption. It is well known that HA is relatively less bioactive and non-resorbable (Daculsi et al., 1989). The studies on HA and silica oxide-based (HA/SiO) in the rabbit calvaria defect model showed an average area fraction of newly formed bone of 12.32±10.36% for the empty control, 17.47±6.42% for the xenogenic hydroxyapatite -based granules group, and 21.2±5.32% for the group treated with synthetic hydroxyapatite/silica oxide -based granules (Kruse et al., 2011). The results are poorer than ours although it is worth noticing - in every group including control one. The recent studies on four differently composed nano-HA/CS-based bone substituting materials showed better results than ours (Teotia et al., 2017). The advantages of HA/CS materials as well as benefits of additional application of zoledronic acid and/or BMP incorporated into this material was proven. Similarly to our results, control group defects were filled with fibrous tissue with only very little bone formation from the periphery of the defect after 8 weeks of healing. Similar to our study, the authors found osteogenic cells penetrating the granules proving the osteoconductvity of the material. The bone formation in treated defects started around the granules. In the group treated with nano-HA/CS alone, similarly to our nano-Ha group, extensive graft resorption and loss of proper interconnected 3D structure was seen, which may possibly limit the space available for cell infiltration and also their interconnectivity (Teotia et al., 2017). Results comparable to our results on bone defect regeneration with the application of nano-HA was achieved in another study. After 8 weeks\nobservation the authors found that bone defects filled with nano-HA regenerated in 32.6%±10.3% and in 39.3%±12.8% in case of additional application of rh-VEGF (Du et al., 2015). Pore size and porosity play an important role in bone ingrowth, because pores allow the migration, as well as proliferation of osteogenic cells and can even change bone specific gene expression (Karageorgiou and Kaplan, 2005; Kunert-Keil et al., 2009; Gredes et al., 2012a; Gredes et al., 2012b). Small pores cannot contribute to bone formation, because they are infiltrated with avascular tissue instead (Chvapil et al., 1969); pores with a minimum diameter of 50 μm are required for bone ingrowth (Welsh et al., 1971). Other studies have shown better bone formation when the pore size was 300-400 µm (Tsuruga et al., 1997; Kuboki et al., 2001). Larger pores are favorable to vascularization, high oxygenation, and subsequent bone formation, whereas smaller pores may favor osteochondral ossification. However, modified extrusion methods for processing block bone is more important than pore size for bone formation. The threshold of porosity is known to be approximately 60%, and bone substitutes with a porosity of < 60% tend to have small pores and few pore interconnections (Li et al., 2003; Hing et al., 2004). In the present study, the pore size of the nano-HA ranged to 50μm, and all had a porosity > 70%."
    }, {
      "heading" : "Conclusion",
      "text" : "Within the limitation of the animal model study, it can be concluded that the evaluated new experimental nano-HA can be used as bone substitute. This new material serves as an osteoconductive scaffold comparably to xenogeneic bovine bone graft."
    }, {
      "heading" : "Figure and table description:",
      "text" : "Fig. 1: Longitudinal incision exposing the Wistar rat calvaria. Intraoperative photograph.\nFig. 2: Bone defect created in rat calvaria. Intraoperative photograph.\nFig. 3: Bone defect filled with nano-hydroxyapatite. Intraoperative photograph.\nFig. 4: Bone defect filled with nano-hydroxyapatite in combination with the Jason® collagen membrane. Intraoperative photograph.\nFig. 5: Histological preparations (H.E. and Masson Goldner staining, respectively) of spontaneously healed bone defects. Magnification 100x. BG=Bone Graft, CT-Connective Tissue, NB=New Bone. The arrows mark the transition between the newly formed bone and the connective tissue / bone marrow (borders of the defect).\nFig. 6: Histological preparations (H.E. and Masson Goldner staining, respectively) of bone defects treated with Geistlich Bio-Oss®. Magnification 100x. BG=Bone Graft, NB=New Bone. The arrows mark the transition between the newly formed bone and the connective tissue / bone marrow (borders of the defect).\nFig. 7: Histological preparations (H.E. and Masson Goldner staining, respectively) of bone defects treated with nano-HA + β-TCP. Magnification 100x. BG=Bone Graft, NB=New Bone. The arrows mark the transition between the newly formed bone and the connective tissue / bone marrow (borders of the defect).\nFig. 8: Histological preparations (H.E. and Masson Goldner staining, respectively) of bone defects treated only with nano-HA material. Magnification 100x. BG=Bone Graft, NB=New Bone. The arrows mark the transition between the newly formed bone and the connective tissue / bone marrow (borders of the defect).\nFig. 9: Histological preparations (H.E. and Masson Goldner staining, respectively) of bone defects treated with nano-HA + Jason® collagen membrane. Magnification 100x. CTConnective Tissue, NB=New Bone. The arrows mark the transition between the newly formed bone and the connective tissue / bone marrow (borders of the defect).\nFig. 10: Micro-CT images of the calvaria after treatment with the different biomaterials; arrows indicate the remaining bone defect after 8 weeks of healing.\nTab. 1: Histomorphometric analyses of rat calvaria. Measurement of bone formation after 8 weeks of healing."
    }, {
      "heading" : "Group-Number Regenerated bone (%)",
      "text" : "Group 1 44.4 ± 8.8\nGroup 2 34.2 ± 8.4\nGroup 3 36.9 ± 10.6\nGroup 4 39.1 ± 8.2\nGroup 5 13.0 ± 6.29\nTab. 2: Post hoc analysis using Tukey Test for histomorphometric analysis shown in table 1\nPost hoc test results (HSD Tukey) (p<0.05) Group 1 Group 2 Group 3 Group 4 Group 5\nGroup 1 0.244715 0.541669 0.802642 0.000139 Group 2 0.244715 0.976438 0.832372 0.001414 Group 3 0.541669 0.976438 0.990259 0.000412 Group 4 0.802642 0.832372 0.990259 0.000208 Group 5 0.000139 0.001414 0.000208 0.000208"
    } ],
    "references" : [ {
      "title" : "Animal models of bone defect repair",
      "author" : [ "Y. An", "R. Friedman" ],
      "venue" : null,
      "citeRegEx" : "An and Friedman,? \\Q1999\\E",
      "shortCiteRegEx" : "An and Friedman",
      "year" : 1999
    }, {
      "title" : "Bone graft materials. An overview of the basic science",
      "author" : [ "T.W. Bauer", "G.F. Muschler" ],
      "venue" : "Clin Orthop Relat Res",
      "citeRegEx" : "Bauer and Muschler,? \\Q2000\\E",
      "shortCiteRegEx" : "Bauer and Muschler",
      "year" : 2000
    }, {
      "title" : "Nonallograft osteoconductive bone graft substitutes",
      "author" : [ "R.W. Bucholz" ],
      "venue" : "Clin Orthop Relat Res",
      "citeRegEx" : "Bucholz,? \\Q2002\\E",
      "shortCiteRegEx" : "Bucholz",
      "year" : 2002
    }, {
      "title" : "Histological evaluation at different times after augmentation of extraction sites grafted with a magnesium-enriched hydroxyapatite: double-blinded randomized controlled trial",
      "author" : [ "L. Canullo", "F. Heinemann", "T. Gedrange", "R. Biffar", "C. Kunert-Keil" ],
      "venue" : "Clin Oral Implants Res",
      "citeRegEx" : "Canullo et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Canullo et al\\.",
      "year" : 2013
    }, {
      "title" : "Some chemical and biological characteristics of a new collagen-polymer compound material",
      "author" : [ "M. Chvapil", "R. Holusa", "K. Kliment", "M. Stoll" ],
      "venue" : "J Biomed Mater Res",
      "citeRegEx" : "Chvapil et al\\.,? \\Q1969\\E",
      "shortCiteRegEx" : "Chvapil et al\\.",
      "year" : 1969
    }, {
      "title" : "Crystal dissolution of biological and ceramic apatites",
      "author" : [ "G. Daculsi", "R.Z. LeGeros", "D. Mitre" ],
      "venue" : "Calcif Tissue Int",
      "citeRegEx" : "Daculsi et al\\.,? \\Q1989\\E",
      "shortCiteRegEx" : "Daculsi et al\\.",
      "year" : 1989
    }, {
      "title" : "Angiogenesis and bone regeneration of porous nano-hydroxyapatite/coralline blocks coated with rhVEGF165 in critical-size alveolar bone defects in vivo",
      "author" : [ "B. Du", "W. Liu", "Y. Deng", "S. Li", "X. Liu", "Y. Gao", "L. Zhou" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "Du et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Du et al\\.",
      "year" : 2015
    }, {
      "title" : "The value of osseous coagulum as a graft material",
      "author" : [ "E. Freeman", "R.S. Turnbull" ],
      "venue" : "J Periodontal Res",
      "citeRegEx" : "Freeman and Turnbull,? \\Q1973\\E",
      "shortCiteRegEx" : "Freeman and Turnbull",
      "year" : 1973
    }, {
      "title" : "Computer-aided design/computer-aided manufacturing of hydroxyapatite scaffolds for bone reconstruction in jawbone atrophy: a systematic review and case report",
      "author" : [ "U. Garagiola", "R. Grigolato", "R. Soldo", "M. Bacchini", "G. Bassi", "R. Roncucci", "S. De Nardi" ],
      "venue" : "Maxillofac Plast Reconstr Surg 38,",
      "citeRegEx" : "Garagiola et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Garagiola et al\\.",
      "year" : 2016
    }, {
      "title" : "Bone substitutes: an update",
      "author" : [ "P.V. Giannoudis", "H. Dinopoulos", "E. Tsiridis" ],
      "venue" : "Injury 36 Suppl",
      "citeRegEx" : "Giannoudis et al\\.,? \\Q2005\\E",
      "shortCiteRegEx" : "Giannoudis et al\\.",
      "year" : 2005
    }, {
      "title" : "Immunohistochemical characterization of nanocrystalline hydroxyapatite silica gel (NanoBone(r)) osteogenesis: a study on biopsies from human jaws",
      "author" : [ "W. Gotz", "T. Gerber", "B. Michel", "S. Lossdorfer", "K.O. Henkel", "F. Heinemann" ],
      "venue" : "Clin Oral Implants Res",
      "citeRegEx" : "Gotz et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Gotz et al\\.",
      "year" : 2008
    }, {
      "title" : "A preliminary study in osteoinduction by a nano-crystalline hydroxyapatite in the mini pig",
      "author" : [ "W. Gotz", "S. Lenz", "C. Reichert", "K.O. Henkel", "V. Bienengraber", "L. Pernicka", "K.K. Gundlach", "T. Gredes", "T. Gerber", "T. Gedrange", "F. Heinemann" ],
      "venue" : "Folia Histochem Cytobiol",
      "citeRegEx" : "Gotz et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Gotz et al\\.",
      "year" : 2010
    }, {
      "title" : "Histological and molecular-biological analyses of poly(3-hydroxybutyrate) (PHB) patches for enhancement of bone regeneration",
      "author" : [ "T. Gredes", "T. Gedrange", "C. Hinuber", "M. Gelinsky", "C. Kunert-Keil" ],
      "venue" : "Ann Anat",
      "citeRegEx" : "Gredes et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Gredes et al\\.",
      "year" : 2015
    }, {
      "title" : "Bone substitution materials on the basis of BONITmatrix(R) up-regulate mRNA expression of IGF1 and Col1a1",
      "author" : [ "T. Gredes", "F. Heinemann", "M. Dominiak", "H. Mack", "T. Gedrange", "A. Spassov", "T. Klinke", "C. Kunert-Keil" ],
      "venue" : "Ann Anat",
      "citeRegEx" : "Gredes et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Gredes et al\\.",
      "year" : 2012
    }, {
      "title" : "Influence of BONITmatrix((R)) and OSSA NOVA on the expression of bone specific genes",
      "author" : [ "T. Gredes", "T. Kracht", "T. Gedrange", "C. Kunert-Keil" ],
      "venue" : "Ann Anat",
      "citeRegEx" : "Gredes et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Gredes et al\\.",
      "year" : 2012
    }, {
      "title" : "Osteogenic capacity of transgenic flax scaffolds",
      "author" : [ "T. Gredes", "M. Wrobel-Kwiatkowska", "M. Dominiak", "T. Gedrange", "C. Kunert-Keil" ],
      "venue" : "Biomed Tech (Berl)",
      "citeRegEx" : "Gredes et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Gredes et al\\.",
      "year" : 2012
    }, {
      "title" : "Hydroxyapatite granules used in the obliteration of mastoid cavities in rats",
      "author" : [ "R. Hamerschmidt", "R.F. Santos", "J.C. Araujo", "H.J. Stahlke Jr.", "M.A. Agulham", "A.T. Moreira", "M. Mocellin" ],
      "venue" : "Braz J Otorhinolaryngol",
      "citeRegEx" : "Hamerschmidt et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Hamerschmidt et al\\.",
      "year" : 2011
    }, {
      "title" : "Comparison of bone graft matrices for human mesenchymal stem cell-directed osteogenesis",
      "author" : [ "C.T. Harris", "L.F. Cooper" ],
      "venue" : "J Biomed Mater Res A",
      "citeRegEx" : "Harris and Cooper,? \\Q2004\\E",
      "shortCiteRegEx" : "Harris and Cooper",
      "year" : 2004
    }, {
      "title" : "Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects",
      "author" : [ "A.M. Henslee", "P.P. Spicer", "D.M. Yoon", "M.B. Nair", "V.V. Meretoja", "K.E. Witherel", "J.A. Jansen", "A.G. Mikos", "F.K. Kasper" ],
      "venue" : "Acta Biomater",
      "citeRegEx" : "Henslee et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Henslee et al\\.",
      "year" : 2011
    }, {
      "title" : "Mediation of bone ingrowth in porous hydroxyapatite bone graft substitutes",
      "author" : [ "K.A. Hing", "S.M. Best", "K.E. Tanner", "W. Bonfield", "P.A. Revell" ],
      "venue" : "J Biomed Mater Res A",
      "citeRegEx" : "Hing et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Hing et al\\.",
      "year" : 2004
    }, {
      "title" : "Bone formation in rat calvaria ceases within a limited period regardless of completion of defect repair",
      "author" : [ "T. Honma", "T. Itagaki", "M. Nakamura", "S. Kamakura", "I. Takahashi", "S. Echigo", "Y. Sasano" ],
      "venue" : "Oral Dis",
      "citeRegEx" : "Honma et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Honma et al\\.",
      "year" : 2008
    }, {
      "title" : "Long bone defect models for tissue engineering applications: criteria for choice",
      "author" : [ "E.A. Horner", "J. Kirkham", "D. Wood", "S. Curran", "M. Smith", "B. Thomson", "X.B. Yang" ],
      "venue" : "Tissue Eng Part B Rev",
      "citeRegEx" : "Horner et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Horner et al\\.",
      "year" : 2010
    }, {
      "title" : "Porosity of 3D biomaterial scaffolds and osteogenesis",
      "author" : [ "V. Karageorgiou", "D. Kaplan" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "Karageorgiou and Kaplan,? \\Q2005\\E",
      "shortCiteRegEx" : "Karageorgiou and Kaplan",
      "year" : 2005
    }, {
      "title" : "Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue",
      "author" : [ "D.H. Kempen", "L. Lu", "T.E. Hefferan", "L.B. Creemers", "A. Maran", "K.L. Classic", "W.J. Dhert", "M.J. Yaszemski" ],
      "venue" : "engineering. Biomaterials",
      "citeRegEx" : "Kempen et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Kempen et al\\.",
      "year" : 2008
    }, {
      "title" : "Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration",
      "author" : [ "D.H. Kempen", "L. Lu", "A. Heijink", "T.E. Hefferan", "L.B. Creemers", "A. Maran", "M.J. Yaszemski", "W.J. Dhert" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "Kempen et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Kempen et al\\.",
      "year" : 2009
    }, {
      "title" : "Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes",
      "author" : [ "D.H. Kempen", "M.J. Yaszemski", "A. Heijink", "T.E. Hefferan", "L.B. Creemers", "J. Britson", "A. Maran", "K.L. Classic", "W.J. Dhert", "L. Lu" ],
      "venue" : "J Control Release",
      "citeRegEx" : "Kempen et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Kempen et al\\.",
      "year" : 2009
    }, {
      "title" : "Spinal fusion surgery: animal models for tissue-engineered bone",
      "author" : [ "S.N. Khan", "J.M. Lane" ],
      "venue" : "constructs. Biomaterials",
      "citeRegEx" : "Khan and Lane,? \\Q2004\\E",
      "shortCiteRegEx" : "Khan and Lane",
      "year" : 2004
    }, {
      "title" : "Bone regeneration in the presence of a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute material",
      "author" : [ "A. Kruse", "R.E. Jung", "F. Nicholls", "R.A. Zwahlen", "C.H. Hammerle", "F.E. Weber" ],
      "venue" : "Clin Oral Implants Res",
      "citeRegEx" : "Kruse et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Kruse et al\\.",
      "year" : 2011
    }, {
      "title" : "Optimization of bone-tissue engineering in goats",
      "author" : [ "M.C. Kruyt", "W.J. Dhert", "C. Oner", "C.A. van Blitterswijk", "A.J. Verbout", "J.D. de Bruijn" ],
      "venue" : "J Biomed Mater Res B Appl Biomater",
      "citeRegEx" : "Kruyt et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Kruyt et al\\.",
      "year" : 2004
    }, {
      "title" : "Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis",
      "author" : [ "Y. Kuboki", "Q. Jin", "H. Takita" ],
      "venue" : "J Bone Joint Surg Am 83-A Suppl",
      "citeRegEx" : "Kuboki et al\\.,? \\Q2001\\E",
      "shortCiteRegEx" : "Kuboki et al\\.",
      "year" : 2001
    }, {
      "title" : "Biomaterials applicable for alveolar sockets preservation: in vivo and in vitro studies",
      "author" : [ "C. Kunert-Keil", "T. Gredes", "T. Gedrange" ],
      "venue" : "Intech Open,",
      "citeRegEx" : "Kunert.Keil et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Kunert.Keil et al\\.",
      "year" : 2011
    }, {
      "title" : "Morphological evaluation of bone defect regeneration after treatment with two different forms of bone substitution materials on the basis of BONITmatrix",
      "author" : [ "C. Kunert-Keil", "T. Gredrange", "R. Mai", "A. Spassov", "S. Lucke", "T. Klinke", "J. Kalukin", "B.W. Loster", "T. Gredes" ],
      "venue" : "J Physiol Pharmacol",
      "citeRegEx" : "Kunert.Keil et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Kunert.Keil et al\\.",
      "year" : 2009
    }, {
      "title" : "Comparative study of biphasic calcium phosphate with beta-tricalcium phosphate in rat cranial defects--A molecularbiological and histological study",
      "author" : [ "C. Kunert-Keil", "F. Scholz", "T. Gedrange", "T. Gredes" ],
      "venue" : "Ann Anat",
      "citeRegEx" : "Kunert.Keil et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Kunert.Keil et al\\.",
      "year" : 2015
    }, {
      "title" : "Properties of osteoconductive biomaterials: calcium phosphates",
      "author" : [ "R.Z. LeGeros" ],
      "venue" : "Clin Orthop Relat Res",
      "citeRegEx" : "LeGeros,? \\Q2002\\E",
      "shortCiteRegEx" : "LeGeros",
      "year" : 2002
    }, {
      "title" : "Macroporous biphasic calcium phosphate scaffold with high permeability/porosity ratio",
      "author" : [ "S. Li", "J.R. De Wijn", "J. Li", "P. Layrolle", "K. De Groot" ],
      "venue" : "Tissue Eng",
      "citeRegEx" : "Li et al\\.,? \\Q2003\\E",
      "shortCiteRegEx" : "Li et al\\.",
      "year" : 2003
    }, {
      "title" : "Comparative study of healing and remodeling in various bones",
      "author" : [ "T.A. Najjar", "D. Kahn" ],
      "venue" : "J Oral Surg",
      "citeRegEx" : "Najjar and Kahn,? \\Q1977\\E",
      "shortCiteRegEx" : "Najjar and Kahn",
      "year" : 1977
    }, {
      "title" : "Calcium phosphate cements in medicine and dentistry--a review of literature",
      "author" : [ "J. Noetzel", "A.M. Kielbassa" ],
      "venue" : "Schweiz Monatsschr Zahnmed",
      "citeRegEx" : "Noetzel and Kielbassa,? \\Q2005\\E",
      "shortCiteRegEx" : "Noetzel and Kielbassa",
      "year" : 2005
    }, {
      "title" : "Pre-clinical models for oral and periodontal reconstructive therapies",
      "author" : [ "G. Pellegrini", "Y.J. Seol", "R. Gruber", "W.V. Giannobile" ],
      "venue" : "J Dent Res",
      "citeRegEx" : "Pellegrini et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Pellegrini et al\\.",
      "year" : 2009
    }, {
      "title" : "Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters",
      "author" : [ "E. Puljula", "P. Turhanen", "J. Vepsalainen", "M. Monteil", "M. Lecouvey", "J. Weisell" ],
      "venue" : "ACS Med Chem Lett",
      "citeRegEx" : "Puljula et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Puljula et al\\.",
      "year" : 2015
    }, {
      "title" : "The critical size defect as an experimental model for craniomandibulofacial nonunions",
      "author" : [ "J.P. Schmitz", "J.O. Hollinger" ],
      "venue" : "Clin Orthop Relat Res",
      "citeRegEx" : "Schmitz and Hollinger,? \\Q1986\\E",
      "shortCiteRegEx" : "Schmitz and Hollinger",
      "year" : 1986
    }, {
      "title" : "Preclinical methods for the evaluation of periodontal regeneration in vivo",
      "author" : [ "Y.J. Seol", "G. Pellegrini", "L.M. Franco", "P.C. Chang", "C.H. Park", "W.V. Giannobile" ],
      "venue" : "Methods Mol Biol",
      "citeRegEx" : "Seol et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Seol et al\\.",
      "year" : 2010
    }, {
      "title" : "The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects",
      "author" : [ "K. Takagi", "M.R. Urist" ],
      "venue" : "Ann Surg",
      "citeRegEx" : "Takagi and Urist,? \\Q1982\\E",
      "shortCiteRegEx" : "Takagi and Urist",
      "year" : 1982
    }, {
      "title" : "Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate",
      "author" : [ "Y. Takahashi", "M. Yamamoto", "Y. Tabata" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "Takahashi et al\\.,? \\Q2005\\E",
      "shortCiteRegEx" : "Takahashi et al\\.",
      "year" : 2005
    }, {
      "title" : "Gelatin-Modified Bone Substitute with Bioactive Molecules Enhance Cellular Interactions and Bone Regeneration",
      "author" : [ "A.K. Teotia", "A. Gupta", "D.B. Raina", "L. Lidgren", "A. Kumar" ],
      "venue" : "ACS Appl Mater Interfaces",
      "citeRegEx" : "Teotia et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Teotia et al\\.",
      "year" : 2016
    }, {
      "title" : "Nano-Hydroxyapatite Bone Substitute Functionalized with Bone Active Molecules for Enhanced Cranial Bone Regeneration",
      "author" : [ "A.K. Teotia", "D.B. Raina", "C. Singh", "N. Sinha", "H. Isaksson", "M. Tagil", "L. Lidgren", "A. Kumar" ],
      "venue" : "ACS Appl Mater Interfaces",
      "citeRegEx" : "Teotia et al\\.,? \\Q2017\\E",
      "shortCiteRegEx" : "Teotia et al\\.",
      "year" : 2017
    }, {
      "title" : "Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis",
      "author" : [ "E. Tsuruga", "H. Takita", "H. Itoh", "Y. Wakisaka", "Y. Kuboki" ],
      "venue" : "J Biochem",
      "citeRegEx" : "Tsuruga et al\\.,? \\Q1997\\E",
      "shortCiteRegEx" : "Tsuruga et al\\.",
      "year" : 1997
    }, {
      "title" : "Bone differentiation in porous hydroxyapatite in baboons is regulated by the geometry of the substratum: implications for reconstructive craniofacial surgery",
      "author" : [ "S.P. van Eeden", "U. Ripamonti" ],
      "venue" : "Plast Reconstr Surg",
      "citeRegEx" : "Eeden and Ripamonti,? \\Q1994\\E",
      "shortCiteRegEx" : "Eeden and Ripamonti",
      "year" : 1994
    }, {
      "title" : "Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats",
      "author" : [ "J.C. Wang", "L.E. Kanim", "S. Yoo", "P.A. Campbell", "A.J. Berk", "J.R. Lieberman" ],
      "venue" : "J Bone Joint Surg Am 85-A,",
      "citeRegEx" : "Wang et al\\.,? \\Q2003\\E",
      "shortCiteRegEx" : "Wang et al\\.",
      "year" : 2003
    }, {
      "title" : "Surgical implants. The role of surface porosity in fixation to bone and acrylic",
      "author" : [ "R.P. Welsh", "R.M. Pilliar", "I. Macnab" ],
      "venue" : "J Bone Joint Surg Am",
      "citeRegEx" : "Welsh et al\\.,? \\Q1971\\E",
      "shortCiteRegEx" : "Welsh et al\\.",
      "year" : 1971
    } ],
    "referenceMentions" : [ {
      "referenceID" : 42,
      "context" : "allogenic grafts, or synthetic grafting materials (Takahashi et al., 2005; Kunert-Keil et al., 2011).",
      "startOffset" : 50,
      "endOffset" : 100
    }, {
      "referenceID" : 30,
      "context" : "allogenic grafts, or synthetic grafting materials (Takahashi et al., 2005; Kunert-Keil et al., 2011).",
      "startOffset" : 50,
      "endOffset" : 100
    }, {
      "referenceID" : 1,
      "context" : "that alone or in combination with other materials promotes a bone healing response by providing osteogenic, osteoinductive or osteoconductive properties” (Bauer and Muschler, 2000).",
      "startOffset" : 154,
      "endOffset" : 180
    }, {
      "referenceID" : 1,
      "context" : "with the combination of a particulate bone graft and bone substitute materials are still considered a golden standard of bone augmentation due to the fact that only the autogenous bone has the osteogenic, osteoinductive and osteoconductive properties (Bauer and Muschler, 2000; Takahashi et al., 2005; Kunert-Keil et al., 2011).",
      "startOffset" : 251,
      "endOffset" : 327
    }, {
      "referenceID" : 42,
      "context" : "with the combination of a particulate bone graft and bone substitute materials are still considered a golden standard of bone augmentation due to the fact that only the autogenous bone has the osteogenic, osteoinductive and osteoconductive properties (Bauer and Muschler, 2000; Takahashi et al., 2005; Kunert-Keil et al., 2011).",
      "startOffset" : 251,
      "endOffset" : 327
    }, {
      "referenceID" : 30,
      "context" : "with the combination of a particulate bone graft and bone substitute materials are still considered a golden standard of bone augmentation due to the fact that only the autogenous bone has the osteogenic, osteoinductive and osteoconductive properties (Bauer and Muschler, 2000; Takahashi et al., 2005; Kunert-Keil et al., 2011).",
      "startOffset" : 251,
      "endOffset" : 327
    }, {
      "referenceID" : 42,
      "context" : "Since no bone substitution material has shown similar osteogenic properties to autologous bone up-to-date, new materials are being sought (Takahashi et al., 2005; Kunert-Keil et al., 2011).",
      "startOffset" : 138,
      "endOffset" : 188
    }, {
      "referenceID" : 30,
      "context" : "Since no bone substitution material has shown similar osteogenic properties to autologous bone up-to-date, new materials are being sought (Takahashi et al., 2005; Kunert-Keil et al., 2011).",
      "startOffset" : 138,
      "endOffset" : 188
    }, {
      "referenceID" : 33,
      "context" : "Calcium phosphates such as hydroxyapatite (HA), Ca10(PO4)6(OH)2, and beta-tricalcium phosphate (β-TCP), Ca3(PO4)2, composed of the same ions as the main mineral constituent of bone, are attractive implant materials for bone regeneration because they are biocompatible, osteoconductive, and produce no systemic toxicity or immunological reactions (LeGeros, 2002; Giannoudis et al., 2005).",
      "startOffset" : 346,
      "endOffset" : 386
    }, {
      "referenceID" : 9,
      "context" : "Calcium phosphates such as hydroxyapatite (HA), Ca10(PO4)6(OH)2, and beta-tricalcium phosphate (β-TCP), Ca3(PO4)2, composed of the same ions as the main mineral constituent of bone, are attractive implant materials for bone regeneration because they are biocompatible, osteoconductive, and produce no systemic toxicity or immunological reactions (LeGeros, 2002; Giannoudis et al., 2005).",
      "startOffset" : 346,
      "endOffset" : 386
    }, {
      "referenceID" : 36,
      "context" : "Until now, HA-based biomaterials are the most abundant materials used in modern bone substitution (Noetzel and Kielbassa, 2005; Gotz et al., 2008; Hamerschmidt et al., 2011; Canullo et al., 2013; Kunert-Keil et al., 2015).",
      "startOffset" : 98,
      "endOffset" : 221
    }, {
      "referenceID" : 10,
      "context" : "Until now, HA-based biomaterials are the most abundant materials used in modern bone substitution (Noetzel and Kielbassa, 2005; Gotz et al., 2008; Hamerschmidt et al., 2011; Canullo et al., 2013; Kunert-Keil et al., 2015).",
      "startOffset" : 98,
      "endOffset" : 221
    }, {
      "referenceID" : 16,
      "context" : "Until now, HA-based biomaterials are the most abundant materials used in modern bone substitution (Noetzel and Kielbassa, 2005; Gotz et al., 2008; Hamerschmidt et al., 2011; Canullo et al., 2013; Kunert-Keil et al., 2015).",
      "startOffset" : 98,
      "endOffset" : 221
    }, {
      "referenceID" : 3,
      "context" : "Until now, HA-based biomaterials are the most abundant materials used in modern bone substitution (Noetzel and Kielbassa, 2005; Gotz et al., 2008; Hamerschmidt et al., 2011; Canullo et al., 2013; Kunert-Keil et al., 2015).",
      "startOffset" : 98,
      "endOffset" : 221
    }, {
      "referenceID" : 32,
      "context" : "Until now, HA-based biomaterials are the most abundant materials used in modern bone substitution (Noetzel and Kielbassa, 2005; Gotz et al., 2008; Hamerschmidt et al., 2011; Canullo et al., 2013; Kunert-Keil et al., 2015).",
      "startOffset" : 98,
      "endOffset" : 221
    }, {
      "referenceID" : 2,
      "context" : "There are numerous methods of obtaining HA, including: wet, dry, flux and sol-gel reactions, however, the most popular method is the wet method (Bucholz, 2002; LeGeros, 2002; Giannoudis et al., 2005).",
      "startOffset" : 144,
      "endOffset" : 199
    }, {
      "referenceID" : 33,
      "context" : "There are numerous methods of obtaining HA, including: wet, dry, flux and sol-gel reactions, however, the most popular method is the wet method (Bucholz, 2002; LeGeros, 2002; Giannoudis et al., 2005).",
      "startOffset" : 144,
      "endOffset" : 199
    }, {
      "referenceID" : 9,
      "context" : "There are numerous methods of obtaining HA, including: wet, dry, flux and sol-gel reactions, however, the most popular method is the wet method (Bucholz, 2002; LeGeros, 2002; Giannoudis et al., 2005).",
      "startOffset" : 144,
      "endOffset" : 199
    }, {
      "referenceID" : 8,
      "context" : "During degradation and the resorption of β-TCP space for new bone formation is provided (Garagiola et al., 2016).",
      "startOffset" : 88,
      "endOffset" : 112
    }, {
      "referenceID" : 8,
      "context" : "Additionally, use of nano-HA has a positive effect on protein adhesion, cell adhesion and proliferation (Garagiola et al., 2016; Teotia et al., 2017).",
      "startOffset" : 104,
      "endOffset" : 149
    }, {
      "referenceID" : 44,
      "context" : "Additionally, use of nano-HA has a positive effect on protein adhesion, cell adhesion and proliferation (Garagiola et al., 2016; Teotia et al., 2017).",
      "startOffset" : 104,
      "endOffset" : 149
    }, {
      "referenceID" : 17,
      "context" : "It has been shown that both pore size and porosity have effects on mineralization and bone formation (Harris and Cooper, 2004; Kruyt et al., 2004).",
      "startOffset" : 101,
      "endOffset" : 146
    }, {
      "referenceID" : 28,
      "context" : "It has been shown that both pore size and porosity have effects on mineralization and bone formation (Harris and Cooper, 2004; Kruyt et al., 2004).",
      "startOffset" : 101,
      "endOffset" : 146
    }, {
      "referenceID" : 22,
      "context" : "The nanometer grain sizes and high porosity of surface increase osteoblast function and allows for faster proliferation, adhesion and differentiation (Karageorgiou and Kaplan, 2005).",
      "startOffset" : 150,
      "endOffset" : 181
    }, {
      "referenceID" : 38,
      "context" : "Additional application of the bisphosphonates to such composed material can rule the time of CS resorption in order to achieve better properties (Puljula et al., 2015).",
      "startOffset" : 145,
      "endOffset" : 167
    }, {
      "referenceID" : 12,
      "context" : "Histomorphometric analyses were evaluated by 2 independent observers and performed on composed pictures showing the complete cavity at a magnification of x100 as described previously (Gredes et al., 2015; Kunert-Keil et al., 2015).",
      "startOffset" : 183,
      "endOffset" : 230
    }, {
      "referenceID" : 32,
      "context" : "Histomorphometric analyses were evaluated by 2 independent observers and performed on composed pictures showing the complete cavity at a magnification of x100 as described previously (Gredes et al., 2015; Kunert-Keil et al., 2015).",
      "startOffset" : 183,
      "endOffset" : 230
    }, {
      "referenceID" : 37,
      "context" : "evaluation of horizontal ridge augmentation (Pellegrini et al., 2009; Seol et al., 2010).",
      "startOffset" : 44,
      "endOffset" : 88
    }, {
      "referenceID" : 40,
      "context" : "evaluation of horizontal ridge augmentation (Pellegrini et al., 2009; Seol et al., 2010).",
      "startOffset" : 44,
      "endOffset" : 88
    }, {
      "referenceID" : 39,
      "context" : "popularity for use in the discussed purposes are mostly due to the following: the calvaria bone structure allows for reproducibility of the defects that are easily evaluated by radiographic and histological analysis; the anatomic location allows for surgical approach and facilitates surgical protocol; and the model has been widely used and studied, allowing a precise comparison of grafted substances (Schmitz and Hollinger, 1986; An and Friedman, 1999; Gredes et al., 2012c; Kunert-Keil et al., 2015).",
      "startOffset" : 403,
      "endOffset" : 503
    }, {
      "referenceID" : 0,
      "context" : "popularity for use in the discussed purposes are mostly due to the following: the calvaria bone structure allows for reproducibility of the defects that are easily evaluated by radiographic and histological analysis; the anatomic location allows for surgical approach and facilitates surgical protocol; and the model has been widely used and studied, allowing a precise comparison of grafted substances (Schmitz and Hollinger, 1986; An and Friedman, 1999; Gredes et al., 2012c; Kunert-Keil et al., 2015).",
      "startOffset" : 403,
      "endOffset" : 503
    }, {
      "referenceID" : 32,
      "context" : "popularity for use in the discussed purposes are mostly due to the following: the calvaria bone structure allows for reproducibility of the defects that are easily evaluated by radiographic and histological analysis; the anatomic location allows for surgical approach and facilitates surgical protocol; and the model has been widely used and studied, allowing a precise comparison of grafted substances (Schmitz and Hollinger, 1986; An and Friedman, 1999; Gredes et al., 2012c; Kunert-Keil et al., 2015).",
      "startOffset" : 403,
      "endOffset" : 503
    }, {
      "referenceID" : 39,
      "context" : "In order to stress the bone healing ability of an organism to nonunion, the critical-size defect must be large enough to create a non-viable space that inhibits indirect bone healing to bridge the defect (Schmitz and Hollinger, 1986).",
      "startOffset" : 204,
      "endOffset" : 233
    }, {
      "referenceID" : 10,
      "context" : "This is in accordance with earlier published results when using calcium phosphate ceramics in both rat and humans (Gotz et al., 2008; Canullo et al., 2013; KunertKeil et al., 2015).",
      "startOffset" : 114,
      "endOffset" : 180
    }, {
      "referenceID" : 3,
      "context" : "This is in accordance with earlier published results when using calcium phosphate ceramics in both rat and humans (Gotz et al., 2008; Canullo et al., 2013; KunertKeil et al., 2015).",
      "startOffset" : 114,
      "endOffset" : 180
    }, {
      "referenceID" : 10,
      "context" : "Later, these vessels form an intergranular network which probably transports osteoblastic precursor cells into the granules (Gotz et al., 2008).",
      "startOffset" : 124,
      "endOffset" : 143
    }, {
      "referenceID" : 11,
      "context" : "osteogenesis, and subsequent remodeling of the newly formed bone (Gotz et al., 2010).",
      "startOffset" : 65,
      "endOffset" : 84
    }, {
      "referenceID" : 5,
      "context" : "It is well known that HA is relatively less bioactive and non-resorbable (Daculsi et al., 1989).",
      "startOffset" : 73,
      "endOffset" : 95
    }, {
      "referenceID" : 27,
      "context" : "the group treated with synthetic hydroxyapatite/silica oxide -based granules (Kruse et al., 2011).",
      "startOffset" : 77,
      "endOffset" : 97
    }, {
      "referenceID" : 44,
      "context" : "materials showed better results than ours (Teotia et al., 2017).",
      "startOffset" : 42,
      "endOffset" : 63
    }, {
      "referenceID" : 44,
      "context" : "In the group treated with nano-HA/CS alone, similarly to our nano-Ha group, extensive graft resorption and loss of proper interconnected 3D structure was seen, which may possibly limit the space available for cell infiltration and also their interconnectivity (Teotia et al., 2017).",
      "startOffset" : 260,
      "endOffset" : 281
    }, {
      "referenceID" : 6,
      "context" : "8% in case of additional application of rh-VEGF (Du et al., 2015).",
      "startOffset" : 48,
      "endOffset" : 65
    }, {
      "referenceID" : 22,
      "context" : "Pore size and porosity play an important role in bone ingrowth, because pores allow the migration, as well as proliferation of osteogenic cells and can even change bone specific gene expression (Karageorgiou and Kaplan, 2005; Kunert-Keil et al., 2009; Gredes et al., 2012a; Gredes et al., 2012b).",
      "startOffset" : 194,
      "endOffset" : 295
    }, {
      "referenceID" : 31,
      "context" : "Pore size and porosity play an important role in bone ingrowth, because pores allow the migration, as well as proliferation of osteogenic cells and can even change bone specific gene expression (Karageorgiou and Kaplan, 2005; Kunert-Keil et al., 2009; Gredes et al., 2012a; Gredes et al., 2012b).",
      "startOffset" : 194,
      "endOffset" : 295
    }, {
      "referenceID" : 4,
      "context" : "Small pores cannot contribute to bone formation, because they are infiltrated with avascular tissue instead (Chvapil et al., 1969); pores with a minimum diameter of 50 μm are required for bone ingrowth (Welsh et al.",
      "startOffset" : 108,
      "endOffset" : 130
    }, {
      "referenceID" : 48,
      "context" : ", 1969); pores with a minimum diameter of 50 μm are required for bone ingrowth (Welsh et al., 1971).",
      "startOffset" : 79,
      "endOffset" : 99
    }, {
      "referenceID" : 45,
      "context" : "Other studies have shown better bone formation when the pore size was 300-400 μm (Tsuruga et al., 1997; Kuboki et al., 2001).",
      "startOffset" : 81,
      "endOffset" : 124
    }, {
      "referenceID" : 29,
      "context" : "Other studies have shown better bone formation when the pore size was 300-400 μm (Tsuruga et al., 1997; Kuboki et al., 2001).",
      "startOffset" : 81,
      "endOffset" : 124
    }, {
      "referenceID" : 34,
      "context" : "The threshold of porosity is known to be approximately 60%, and bone substitutes with a porosity of < 60% tend to have small pores and few pore interconnections (Li et al., 2003; Hing et al., 2004).",
      "startOffset" : 161,
      "endOffset" : 197
    }, {
      "referenceID" : 19,
      "context" : "The threshold of porosity is known to be approximately 60%, and bone substitutes with a porosity of < 60% tend to have small pores and few pore interconnections (Li et al., 2003; Hing et al., 2004).",
      "startOffset" : 161,
      "endOffset" : 197
    } ],
    "year" : 2017,
    "abstractText" : "Many types of bone substitute materials are available on the market. Researchers are refining new bone substitutes to make them comparable to autologous grafting materials in treatment of bone defects. The purpose of the study was to evaluate the osseoconductive potential and bone defect regeneration in rat calvaria bone defects treated with new synthetic nanohydroxyapatite. The study was performed on 30 rats divided into 5 equal groups. New preproduction of experimental nano-hydroxyapatite material by NanoSynHap (Poznań, Poland) was tested and compared with commercially available materials. Five mm critical size defects were created and filled with the following bone grafting materials: 1) Geistlich Bio-Oss®; 2) nano-hydroxyapatite + β-TCP; 3) nano-hydroxyapatite; 4) nano-hydroxyapatite + collagen membrane. The last group served as controls without any augmentation. Bone samples from calvaria were harvested for histological and micro-ct evaluation after 8 weeks. New bone formation was observed in all groups. Histomorphometric analysis revealed an amount of regenerated bone between 34.2 and 44.4% in treated bone defects, whereas only 13.0% regenerated bone was found in controls. Interestingly, in group 3, no significant particles of the nano-HA material were found. In contrast, residual bone substitute material could be detected in all other test groups. Micro-CT study confirmed the results of the histological examinations. The new nano-hydroxyapatite provides comparable results to other grafts in the field of bone regeneration.",
    "creator" : "Elsevier"
  }
}